Skip to main content

Belite Bio, Inc

BLTE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001889109

In the last 90 days, Belite Bio, Inc insiders filed 0 open-market purchases and 4 sales; 80 institutions reported holding it in 13F filings for Q2 2026, worth $1.44B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Belite Bio, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
2 insiders, $32.0M in total
Insiders trading
2
Net value
−$32.0M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Belite Bio, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Belite Bio, Inc
NameTitleLast reported holdingLast filingFilings, past year
Lin Yu-HsinChief Executive Officer70,134Sep 9, 20265
Chuang Hao-YuanChief Financial Officer26,038Sep 9, 20265
Scholl Hendrik PeterChief Medical Officer15,000IndirectJun 22, 20263
Mata Nathan L.Chief Scientific Officer0May 8, 202618
Chen Wan-ShanDirector9,096Apr 13, 20262

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 13, 2026 (view filing)Apr 94 daysChuang Hao-YuanChief Financial OfficerSSaleAmerican depositary share−6.20K$181.50−$1.13M−6.2%93.8K after4 lots10b5-1
Apr 13, 2026 (view filing)Apr 94 daysChen Wan-ShanDirectorSSaleAmerican depositary share−1.10K$180.43−$198.5K−10.8%9.10K after10b5-1
Apr 13, 2026 (view filing)Apr 94 daysLin Yu-HsinChief Executive OfficerSSaleAmerican depositary share−9.20K$181.45−$1.67M−5.1%170.9K after4 lots10b5-1
Apr 16, 2026 (view filing)Apr 151 dayMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$168.30−$168.3K−6.0%15.7K after5 lots10b5-1
Apr 20, 2026 (view filing)Apr 164 daysMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$160.38−$160.4K−6.4%14.7K after7 lots10b5-1
Apr 20, 2026 (view filing)Apr 173 daysMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$161.63−$161.6K−6.8%13.7K after6 lots10b5-1
Apr 21, 2026 (view filing)Apr 201 dayMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$163.60−$163.6K−7.3%12.7K after7 lots10b5-1
Apr 22, 2026 (view filing)Apr 211 dayMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$166.00−$166.0K−7.9%11.7K after5 lots10b5-1
Apr 23, 2026 (view filing)Apr 221 dayMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$170.39−$170.4K−8.6%10.7K after9 lots10b5-1
Apr 24, 2026 (view filing)Apr 231 dayMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$166.28−$166.3K−9.4%9.67K after6 lots10b5-1
Apr 27, 2026 (view filing)Apr 243 daysMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$159.56−$159.6K−10.3%8.67K after6 lots10b5-1
Apr 28, 2026 (view filing)Apr 271 dayMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$162.64−$162.6K−11.5%7.67K after5 lots10b5-1
Apr 29, 2026 (view filing)Apr 281 dayMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$159.16−$159.2K−13.0%6.67K after9 lots10b5-1
Apr 30, 2026 (view filing)Apr 291 dayMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$155.82−$155.8K−15.0%5.67K after5 lots10b5-1
May 1, 2026 (view filing)Apr 301 dayMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$156.97−$157.0K−17.6%4.67K after4 lots10b5-1
May 4, 2026 (view filing)May 13 daysMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$155.78−$155.8K−21.4%3.67K after8 lots10b5-1
May 5, 2026 (view filing)May 41 dayMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$155.64−$155.6K−27.3%2.67K after5 lots10b5-1
May 6, 2026 (view filing)May 51 dayMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$155.50−$155.5K−37.5%1.67K after6 lots10b5-1
May 7, 2026 (view filing)May 61 dayMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−1.00K$153.84−$153.8K−60.0%666 after6 lots10b5-1
May 8, 2026 (view filing)May 71 dayMata Nathan L.Chief Scientific OfficerSSaleAmerican depositary share−666$153.21−$102.0K−100.0%0 after4 lots10b5-1
Jun 17, 2026 (view filing)Jun 161 dayScholl Hendrik PeterChief Medical OfficerSSaleAmerican depositary share−10.0K$140.57−$1.41M−28.6%25.0K after8 lots
Jun 22, 2026 (view filing)Jun 184 daysScholl Hendrik PeterChief Medical OfficerSSaleAmerican depositary share−10.0K$145.24−$1.45M−40.0%15.0K after5 lots
Aug 14, 2026 (view filing)6:10 AM ETAug 122 daysLin Yu-HsinChief Executive OfficerSSaleAmerican depositary share−365$180.35−$65.8K−0.2%170.6K after2 lots10b5-1
Aug 14, 2026 (view filing)6:10 AM ETAug 122 daysChuang Hao-YuanChief Financial OfficerSSaleAmerican depositary share−367$180.35−$66.2K−0.4%93.4K after2 lots10b5-1
Sep 9, 2026 (view filing)7:38 PM ETSep 4-85 daysChuang Hao-YuanChief Financial OfficerSSaleAmerican depositary share−67.4K$189.98−$12.8M−72.1%26.0K after19 lots10b5-1
Sep 9, 2026 (view filing)7:39 PM ETSep 4-85 daysLin Yu-HsinChief Executive OfficerSSaleAmerican depositary share−100.4K$190.00−$19.1M−58.9%70.1K after19 lots10b5-1